<DOC>
	<DOCNO>NCT00891228</DOCNO>
	<brief_summary>To determine number men suppression sperm production use daily regimen Nestorone® Gel ( 0 , 8 12 mg ) Testosterone Gel apply transdermally .</brief_summary>
	<brief_title>Study Safety , Sperm Gonadotropin Suppression Contraceptive Gel Normal Men</brief_title>
	<detailed_description />
	<mesh_term>ST 1435</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Inclusion Criteria Men meet follow criterion eligible enrollment trial : 1 . Male volunteer good health confirm physical examination , medical history , clinical laboratory test blood urine time screen 2 . 18 50 year age 3 . BMI ≤ 33 calculated weight Kg/ ( height cm ) 2 4 . No history hormonal therapy use last six month prior first screen visit 5 . Subject agree use recognize effective method contraception partner ( i.e . minimum , use doublebarrier contraception ) course study treatment recovery phase 6 . In opinion investigator , subject able comply protocol , understand sign inform consent HIPAA form 7 . Does meet exclusion criterion . Men meet follow criterion NOT eligible enrollment trial : 1 . Men participate another clinical trial involve investigational drug within last 30 day prior first screen visit 2 . Men live catchment 's area clinic within reasonable distance site 3 . Clinically significant abnormal finding screen 4 . Elevated PSA ( level ≥ 4 ng/mL ) , accord local laboratory normal value 5 . Abnormal serum chemistry value , accord local laboratory normal value indicate liver kidney dysfunction may consider clinically significant . Other abnormal lab value may also exclusionary , discretion investigator 6 . Sperm concentration 15 million/mL one three screen sample 7 . Use androgens body building substance within 6 month first screen visit 8 . Diastolic ( D ) blood pressure ( BP ) ≥ 85 Systolic ( S ) BP ≥ 135 mm Hg ; ( BP take 3 time 5 minute interval mean measurement consider ) 9 . History hypertension , include hypertension control treatment 10 . Known history primary testicular disease disorder hypothalamicpituitary axis 11 . Known hypersensitivity progestins 12 . Family personal history venous thromboembolism 13 . Benign malignant liver tumor ; active liver disease 14 . History breast carcinoma 15 . Known history reproductive dysfunction include vasectomy infertility 16 . Known history cardiac , renal , hepatic prostatic disease 17 . A serious systemic disease diabetes mellitus morbid obesity ( body weight great 120 % ideal body weight BMI limitation ) 18 . History sleep apnea 19 . Known suspected alcoholism drug abuse may affect metabolism/transformation steroid hormone study treatment compliance 20 . Known dermatitis severe skin disorder 21 . Partner known pregnant 22 . Men desire fertility within first 24 week study participation . Men participate competitive sport drug screening prohibit substance ( include anabolic steroid ) routine advise relative temporary hazard participate study may fertility sport status .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Contraception</keyword>
	<keyword>Male Contraception</keyword>
	<keyword>Suppression Sperm Production</keyword>
</DOC>